Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             96 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abortive forms of the neuroleptic malignant syndrome: Four case reports Zivanovic, O.
 1998
 8 Supplement 2 p. S223-S224
2 p.
 artikel
2 A double-blind carbamazepine-controlled efficacy and safety study of vaiproate in impulsivity and violence Mosca, L.D.
 1998
 8 Supplement 2 p. S309-
1 p.
 artikel
3 A double-blind comparison of fluvoxamine and clomipramine in OCD Rouillon, F.
 1998
 8 Supplement 2 p. S260-S261
2 p.
 artikel
4 A European multicenter association study of bipolar and unipolar disorders with dopamine receptor polymorphisms: DRD2, DRD3 and DRD4 Rivelli, S.K.
 1998
 8 Supplement 2 p. S200-
1 p.
 artikel
5 A histochemical demonstration of altered cytochrome oxidase activity in the rat brain by neuroleptics Prince, Jonathan A
 1998
 8 Supplement 2 p. 1-6
6 p.
 artikel
6 Alexithymia in a sample of greek alcoholics 1998
 8 Supplement 2 p. S15-
1 p.
 artikel
7 A multicenter study on the efficacy and tolerability of levosulpiride in the treatment of somatoform disorders Altamural, A.C.
 1998
 8 Supplement 2 p. S305-
1 p.
 artikel
8 Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats Jenck, François
 1998
 8 Supplement 2 p. 161-168
8 p.
 artikel
9 A randomized, double-blind comparison of rapid-acting, intramuscular ziprasidone 2 mg and 20 mg in patients with psychosis and acute agitation Reeves, K.R.
 1998
 8 Supplement 2 p. S232-
1 p.
 artikel
10 Association study between bipolar disorder and candidates genes involved in dopamine metabolism Nilsson, L.
 1998
 8 Supplement 2 p. S191-
1 p.
 artikel
11 Attentional disorders — Working memory and schizophrenia — Comparison of treated and non treated patients Amado-Boccara, I.
 1998
 8 Supplement 2 p. S249-
1 p.
 artikel
12 “Atypical” neuromodulatory profile of glutapyrone, a representative of a novel `class' of amino acid-containing dipeptide-mimicking 1,4-dihydropyridine (DHP) compounds: in vitro and in vivo studies Misane, Ilga
 1998
 8 Supplement 2 p. 329-347
19 p.
 artikel
13 Behavioural and neurochemical evidence that the antimicrobial agent oxolinic acid is a dopamine uptake inhibitor Garcia de Mateos-Verchere, J.
 1998
 8 Supplement 2 p. 255-259
5 p.
 artikel
14 Caffeine place conditioning in rats: comparison with cocaine and ethanol Patkina, Nadezhda A
 1998
 8 Supplement 2 p. 287-291
5 p.
 artikel
15 Cerebrospinal fluid levels of monoamine compounds and cholecystokinin peptides after exposure to standardized barometric pressure Gunnarsson, T.
 1998
 8 Supplement 2 p. S315-
1 p.
 artikel
16 Challenge for early interventions: Onset, prodromal phase and early course of schizophrenia Häfner, H.
 1998
 8 Supplement 2 p. S54-S55
2 p.
 artikel
17 Changes in the character of seizures induced by ehectrostimuiaticn of amygdaia in cats after treatment with choiinotropic drugs Tkachenko, B.I.
 1998
 8 Supplement 2 p. S237-
1 p.
 artikel
18 Characterization of the in vitro receptor binding properties of the novel selective 5-HT1A antagonist [3H]robalzotan Jerning, E.
 1998
 8 Supplement 2 p. S180-S181
2 p.
 artikel
19 Chronic unpredictable stress dissociates glucocorticoid receptor-heat shock protein (hsp) complex in rat hippocampus 1998
 8 Supplement 2 p. S39-
1 p.
 artikel
20 Chronic verapamil modifies striatal and frontal cortex dopamine levels. Sitges, Marı́a
 1998
 8 Supplement 2 p. 105-111
7 p.
 artikel
21 Clinical changes and brain drug concentrations on the third day of substitution of placebo for SSRI treatment Henr, M.E.
 1998
 8 Supplement 2 p. S153-S154
2 p.
 artikel
22 Clinical utility of the hierarchical classification of suicide risk factors Rihmer, Z.
 1998
 8 Supplement 2 p. S163-
1 p.
 artikel
23 Clonidine potentiates the effects of 5-HT1A, 5-HT1B and 5-HT2A/2C antagonists and 8-OH-DPAT in the mouse forced swimming test Redrobe, John P
 1998
 8 Supplement 2 p. 169-173
5 p.
 artikel
24 Comorbidity of the borderline personality disorder and depression 1998
 8 Supplement 2 p. S14-
1 p.
 artikel
25 Comparison of the results of differard statistical analysis on the same data set with the aim of showing early onset of action of antidepressants Niklson, I.A.
 1998
 8 Supplement 2 p. S135-
1 p.
 artikel
26 Correlation of striatal dopamine-2 receptor occupancy and extrapyramidal side-effects during antipsychotic treatment: A 1231IBZM 3PECT study Tauscher, J.
 1998
 8 Supplement 2 p. S230-S231
2 p.
 artikel
27 Depression comorbid with medical illness — Treatment with paroxetine Tylee, A.
 1998
 8 Supplement 2 p. S159-S160
2 p.
 artikel
28 Depressive symptoms and neurotransmitters in cerebrospinal fluid in hypothyroid patientsa Gunnarsson, T.
 1998
 8 Supplement 2 p. S301-S302
2 p.
 artikel
29 Development of physical dependence to lorazepam in rats: The effects of repeated short treatments, dose and age Korkmaz, Seher
 1998
 8 Supplement 2 p. 175-181
7 p.
 artikel
30 Differences between clinician-ratings and self-ratings of depressive symptoms: Implication of personality and other psychiatric symptoms Corruble, E.
 1998
 8 Supplement 2 p. S136-
1 p.
 artikel
31 Discussion 1998
 8 Supplement 2 p. 247-252
6 p.
 artikel
32 Disorder of synaptic homeostasis in depression and its treatment Grahame-Smith, D.G.
 1998
 8 Supplement 2 p. S75-S76
2 p.
 artikel
33 Donepezil improves cognition and global function in Alzheimer's disease: Results from us and multinational phase III clinical trials Petit, H.
 1998
 8 Supplement 2 p. S274-
1 p.
 artikel
34 Double-blind, placebo-Icomparator-controlled study of once daily veniafaxine XR (V-XR) and buspirons (Bsp) in outpatients with generalized anxiety disorder (GAD) Haskins, J.T.
 1998
 8 Supplement 2 p. S269-
1 p.
 artikel
35 Drug treatment of the negative symptoms of schizophrenia King, David J
 1998
 8 Supplement 2 p. 33-42
10 p.
 artikel
36 Dysfunctional components of 5-HT neurotransmission in anxiety and depression Deakin, J.F.W.
 1998
 8 Supplement 2 p. S58-S59
2 p.
 artikel
37 Early life stressors and late life consequences as animal models for schizophrenia Ellenbroek, B.A.
 1998
 8 Supplement 2 p. S95-S96
2 p.
 artikel
38 Effect of bipolar disorder and Lithium treatment on inositol monophosphatase transcription and translation in lymphoid cells Agam, G.
 1998
 8 Supplement 2 p. S186-
1 p.
 artikel
39 Effects of low doses of amisulpride on psychomotor and memory performances in healthy elderly subjects Legangneux, E.
 1998
 8 Supplement 2 p. S211-
1 p.
 artikel
40 Effects of repeated administration of diazepam on serotonergic receptors of 1A, 2 and 3 type in the rat brain 1998
 8 Supplement 2 p. S44-
1 p.
 artikel
41 Effects of the atypical antidepressant trimipramine on field potentials in the low Mg2+-model in guinea pig hippocampal slices Langosch, J.M.
 1998
 8 Supplement 2 p. 209-212
4 p.
 artikel
42 Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats Lagos, Patricia
 1998
 8 Supplement 2 p. 113-120
8 p.
 artikel
43 Efficacy and tolerability of mirtazapine used by elderly depressed patients in The Netherlands Kat, M.G.
 1998
 8 Supplement 2 p. S147-
1 p.
 artikel
44 Fluoxetine addition to risperidone in adult psychotic patients: Pharmacokinstic and clinical consequences Bondolfi, G.
 1998
 8 Supplement 2 p. S222-S223
2 p.
 artikel
45 Growth hormone secretion during sleep in male depressed patients 1998
 8 Supplement 2 p. S19-
1 p.
 artikel
46 5-HT1B receptor stimulation inhibits the K+-evoked [3H]dopamine release from rat striatal synaptosomes Sarhan, H.
 1998
 8 Supplement 2 p. S205-S206
2 p.
 artikel
47 Identifying symptom subtypes in obsessive-compulsive disorder: A factor analytic study Treuer, T.
 1998
 8 Supplement 2 p. S254-
1 p.
 artikel
48 Immune activation in patients with Alzheimer's disease Leblhuber, F.
 1998
 8 Supplement 2 p. S279-
1 p.
 artikel
49 Immunophenotypic study of peripheral blood mononuclear cells in schizophrenic patients Theodoropouloul, St.
 1998
 8 Supplement 2 p. S242-S243
2 p.
 artikel
50 Increased psychological responses and divergent neuroendoerins responses to ipsapirone and m-CPP in patients with panic disorder Broocks, A.
 1998
 8 Supplement 2 p. S265-
1 p.
 artikel
51 Infusional high-dose application of the calcium-channel-blocking and antiglutamatergic agent caroverine in the treatment of alcohol withdrawal (DSM-III-R 291.80) Geretsegger, Christian
 1998
 8 Supplement 2 p. 191-194
4 p.
 artikel
52 Intracerebral perfusion of buspirone in dorsal raphe nucleus: Behavioural consequences on anxiolytic state measured in open-field and elevated plus maze, and on locomotor activity in mice Coubard, S.
 1998
 8 Supplement 2 p. S266-
1 p.
 artikel
53 Locomotor and antidepressant-like effects of 5-HT(1A) agonist LY 228729 in prenatally benzodiazepine-exposed rats Cannizzaro, C
 1998
 8 Supplement 2 p. 27-32
6 p.
 artikel
54 Long term efficacy and safety of olanzapine in patients with inadequate initial response to haloperidol or olanzapine Mallinckrodt, C.
 1998
 8 Supplement 2 p. S228-
1 p.
 artikel
55 Molecular genetics of autism Cook, E.H.
 1998
 8 Supplement 2 p. S106-S107
2 p.
 artikel
56 Neuroprotective role of S12024 against neurodegeneration in the rat dentate gyrus Miguel-Hidalgo, José Javier
 1998
 8 Supplement 2 p. 203-208
6 p.
 artikel
57 Neuroreceptors and OCD subtyping Marazziti, D.
 1998
 8 Supplement 2 p. S125-
1 p.
 artikel
58 Neurotensin in schizophrenia and Parkinson's disease O'Connor, W.T
 1998
 8 Supplement 2 p. S86-
1 p.
 artikel
59 Nitric oxide involvement in neurodegeneration Garthwaite, J.
 1998
 8 Supplement 2 p. S67-
1 p.
 artikel
60 Nitrous oxide may lead to irreversible neuron damage when abused chronically-a case report 1998
 8 Supplement 2 p. S22-S23
2 p.
 artikel
61 Normalization of Padrenoceptor down-regulation by SSRI under chronic stress: A mechanism of action of prophylactic effects of antidepressant drugs Matsushita, T.
 1998
 8 Supplement 2 p. S206-S207
2 p.
 artikel
62 Onset of action in the pharmacologic treatment of dysthymia Jorit, M.C.
 1998
 8 Supplement 2 p. S141-
1 p.
 artikel
63 Pathological gambling: An open-label study with fluoxetine de la Gándam, J.J.
 1998
 8 Supplement 2 p. S295-S296
2 p.
 artikel
64 Patients' satisfaction and acceptability of long-term treatment with ‘Seroquel’: Results of an international study Hellewell, J.S.E.
 1998
 8 Supplement 2 p. S248-
1 p.
 artikel
65 Patterns of c-fos expression induced by fluvoxamine are different after acute vs. chronic oral administration Veening, J.G.
 1998
 8 Supplement 2 p. 213-226
14 p.
 artikel
66 Pharmacokinetics of mirtazapine in combination with amitriptyline Mink, L.
 1998
 8 Supplement 2 p. S146-S147
2 p.
 artikel
67 Pharmacological approaches predicting antidepressant or anxiolytic activities: What is common and what is different Olivier, B.
 1998
 8 Supplement 2 p. S78-
1 p.
 artikel
68 Pindolol augmentation: Single or multiple targets in the brain Artigas, F.
 1998
 8 Supplement 2 p. S97-S98
2 p.
 artikel
69 Polygraphic study of the effects of milnacipran 100 mg on the sleep of depressed in-patients Faivre, T.
 1998
 8 Supplement 2 p. S181-S182
2 p.
 artikel
70 Prozac versus anafranil in the therapy of social phobia and agoraphobia 1998
 8 Supplement 2 p. S27-
1 p.
 artikel
71 Pulse loading versus gradual dosing of intravenous clomipramine in obsessive-compulsive disorder Koran, Lorrin M
 1998
 8 Supplement 2 p. 121-126
6 p.
 artikel
72 Randomized, double-blind comparison of venlafaxine and amitriptyline in outpatients with major depression Benedictis, E.
 1998
 8 Supplement 2 p. S175-
1 p.
 artikel
73 Rapid psychiatric treatment of detoxification from opiates Conte, G.L.
 1998
 8 Supplement 2 p. S285-
1 p.
 artikel
74 Reinstatement of cocaine self-administration behavior by priming with cocaine injected into the nucleus accumbens septi in rats Bespalov, A.Y.
 1998
 8 Supplement 2 p. S290-
1 p.
 artikel
75 Relatives' attitudes, as a factor affecting patients' compliance with antipsychotic drug therapy 1998
 8 Supplement 2 p. S33-S34
2 p.
 artikel
76 Risperidone augmentation of clozapin and olanzapine for refractory schizophrenia Mantonakis, I.
 1998
 8 Supplement 2 p. S233-
1 p.
 artikel
77 Risperidone increases serotonin output in the rat frontal cortex: Rote of α2 and 5-HT1D receptor antagonism Svensson, T.H.
 1998
 8 Supplement 2 p. S211-
1 p.
 artikel
78 Self-administration of the cannabinoid agonist WIN 55,212-2 and morphine in mice: evidence for a common neurobiological mechanism 1998
 8 Supplement 2 p. S41-S42
2 p.
 artikel
79 Serum cholinesterase and red blood cell acetylchollnesterase activity in patients with Alzheimer's disease and the effect of aluminofluoride complexes Strunecki, A.
 1998
 8 Supplement 2 p. S280-
1 p.
 artikel
80 SSRI discontinuation syndrome treated with fluoxetine Benazzi, F.
 1998
 8 Supplement 2 p. S192-
1 p.
 artikel
81 SSRI normalizes β-adrenoceptor down-regulation in rat brain under chronic unpredictable stress 1998
 8 Supplement 2 p. S44-
1 p.
 artikel
82 Studies on the role of nicotinic acetylcholine receptors in the discriminative and aversive stimulus properties of ethanol in the rat Bienkowskia , Przemyslaw
 1998
 8 Supplement 2 p. 79-87
9 p.
 artikel
83 Suicide and psychopharmacology 1998
 8 Supplement 2 p. S4-
1 p.
 artikel
84 Thalamic and ventricular volumes in siblings discordant for schizophrenia and normal controls Staal, W.G.
 1998
 8 Supplement 2 p. S217-S218
2 p.
 artikel
85 The case of combined somatogenic, psychogenic and endogenic depression in patient with severe burn 1998
 8 Supplement 2 p. S10-
1 p.
 artikel
86 The effect of some calcium antagonists on phenobarbital withdrawal syndrome in rats Lazarova, M.
 1998
 8 Supplement 2 p. S289-
1 p.
 artikel
87 The effects of prophylactic treatment with lithium on immunological function in patients with mood disorders 1998
 8 Supplement 2 p. S34-S35
2 p.
 artikel
88 The efficacy of clozapine in 111 schizophrenic patients during a 2-year follow-up period in Turkey Coşar, B.
 1998
 8 Supplement 2 p. S213-
1 p.
 artikel
89 The influence of the atypical antidepressant trimipramine on long term potentiation in guinea pig hippocampal slices Langosch, J.M.
 1998
 8 Supplement 2 p. S169-
1 p.
 artikel
90 The role of cortical NMDA receptors in the neuroleptic action Ossowska, K.
 1998
 8 Supplement 2 p. S238-
1 p.
 artikel
91 The usage of psychopharmaca in a community mental health center 1998
 8 Supplement 2 p. S31-
1 p.
 artikel
92 The use of citalopram in a multimodal approach to the therapy of bulimia nervosa Calandra, C.
 1998
 8 Supplement 2 p. S310-
1 p.
 artikel
93 The use of psychotropics in child psychiatry practice in the community mental health centre 1998
 8 Supplement 2 p. S23-S24
2 p.
 artikel
94 Venlafaxine prevents recurrence of depression Hackett, D.
 1998
 8 Supplement 2 p. S158-
1 p.
 artikel
95 Venlafaxine withdrawal syndrome Ricci, M.
 1998
 8 Supplement 2 p. S196-S197
2 p.
 artikel
96 Visualisation of dopamine-2 receptor blockade in psychotic patients treated with zotepine Barnas, C.
 1998
 8 Supplement 2 p. S249-S250
2 p.
 artikel
                             96 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland